Indeed, intervention studies suggest that even a modest (5%) weight loss, achieved by low-calorie diet, substantially improves metabolic functions in AT, liver and muscle insulin sensitivity, and pancreatic β-cell function (61), suggesting that changes in AT biology and metabolism are critical regulators of disease pathogenesis in obesity and T2D. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.